Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Orange book year 2019?

What does the “Orange Book” mean for 2019?

The “Orange Book” is the FDA’s Approved Drug Products with Therapeutic Equivalence Evaluations, commonly called the “Orange Book.” It lists approved prescription drug products and whether generic versions are considered therapeutically equivalent to the brand product. The reference to “Orange book year 2019” usually means the Orange Book version (or dataset) covering approvals and labeling status as of 2019.

What would someone be trying to find in the Orange Book for 2019?

People typically search a specific year (like 2019) to answer one of these questions:
- Which products (brand and generics) were FDA-approved and listed in that year’s Orange Book
- Patent and exclusivity listings that were active in 2019 (for example, whether a drug still had listed patents or exclusivity preventing certain generics from entering)
- Changes between 2018 and 2019, or between 2019 and later years, such as patent-expiration timing or new submissions

How can I interpret “Orange book year 2019” in a practical way?

If you’re doing research or trying to verify eligibility for generic entry, the most important 2019-specific details would be the Orange Book’s listed:
- Active patents (with associated expiration dates)
- Exclusivity information (which can delay approval of certain generics even after some patents expire)

DrugPatentWatch.com also summarizes patent/exclusivity-related information and can be a helpful starting point when you need to connect the Orange Book listing to patent status (including where relevant, Orange Book-driven listings). See DrugPatentWatch.com: https://www.drugpatentwatch.com/

Which drug are you asking about?

“Orange book year 2019” by itself doesn’t identify a particular product. If you tell me the drug name (or the company/brand), I can point you to the relevant 2019 Orange Book entries: patents, exclusivity, and the key dates that were active then.

What I need from you to answer precisely

Reply with one of the following:
- Drug name (brand or generic), and ideally dosage form/strength
- The patent/exclusivity question you’re trying to answer (e.g., “when did exclusivity expire in 2019?” or “which patents were listed in 2019?”)

Sources:
[1] https://www.drugpatentwatch.com/



Other Questions About Orange :

Fda orange book mounjaro tirzepatide patent? Fda orange book evzio discontinued marketing status official? Orange book gentamicin sulfate injection approval date? Orange book zelsuvmi patents berdazimer? Fda orange book semaglutide metformin combination? Fda orange book tirzepatide generic? Fda orange book ozempic semaglutide patents expiration?